Endologix LLC

Congrats to Dr. David Loran and team for completing the first #PTAB case at UPMC Harrisburg. This was the 2nd case for Dr. David Loran, but the first at Harrisburg. The patient had previous #endovascular interventions that failed. Dr. Loran finished this case in a little over an hour and was able to restore flow to the lower extremeties using the #DETOURSystem. 👏👏 Learn about the DETOUR System here: https://lnkd.in/geiZmcEX #PeripheralArteryDisease #medtech #healthcareinnovation #medtwitter #cardiotwitter #endovascularinnovation #medicalinnovation #percutaneous

Start your day with us on Saturday at #ISWVS for our sponsored breakfast symposium. The entire #Endologix portfolio of #endovascularinnovation will be on the agenda: the #DETOURSystem, the #AFX2 Endovascular AAA system, and the #ALTO stent graft. Panelists, including International Society for Women Vascular Surgeons President Palma Shaw, will be sharing their real-world experiences with these technologies and how they are uniquely addressing the needs of patients with vascular disease. You can also be a part of the conversation by taking part in the live Q&A. 🗓️ Saturday, May 2 - 7:00AM "Beyond Boundaries: Modern Solutions Across the Aortic and Peripheral Continuum" 📌Segment 1: Precision in EVAR - Expanding Treatment Options Speaker: Dr. Palma Shaw 📌Segment 2: Proven Performance & Durability in EVAR Speaker: Dr. Kathryn Bowser 📌Segment 3: Expanding the Peripheral Algorithm - PTAB with DETOUR Speaker: Dr. Yana Etkin 📌Panel Discussion + Q&A Important Safety Information: https://lnkd.in/gPBKk77p #PeripheralArteryDisease #medtech #healthcareinnovation #medtwitter #cardiotwitter #medicalinnovation

Late-breaking at #SCAI2026: #PTAB delivers strong clinical outcomes irrespective of the number of run-off vessels, making it a promising alternative to open surgical bypass for patients with complex #PAD - even those with just single vessel runoff. ✅ Primary patency at one, two, and three years was similar for patients with one vessel runoff (84.4%, 68.0%, and 52.1%) compared to patients with more than one vessel runoff (82.1%, 68.1%, and 59.5%).* Read the press release: https://lnkd.in/gEzn9Vac Important Safety Information: https://lnkd.in/gQvqV2Kn Sameh Sayfo, MD, MBA, FACC, FSCAI Society for Cardiovascular Angiography & Interventions #DETOURSystem #PeripheralArteryDisease #medtech #healthcareinnovation #medtwitter #cardiotwitter #endovascularinnovation #medicalinnovation #percutaneous Disclaimer: The DETOUR System is not approved for use outside of the U.S.

Big congratulations to Dr. Richard Rogers on his first case with the #AFX2 #Endovascular AAA System. This is a great milestone for the entire team at HonorHealth Deer Valley and an exciting step in advancing #endovascular treatment options for patients with #AbdominalAorticAneurysm. Learn more about AFX2: https://lnkd.in/gPxw627K ISI: https://lnkd.in/g4QUkakB #vascularsurgery #medtech #healthcareinnovation #VascularInnovation #MedicalEducation #medicalinnovation #Endologix

April is Limb Loss/Limb Difference Awareness month! #LLLDAM Here at #Endologix, we proudly support the limb loss/limb difference community. Special thanks to the Amputee Coalition for their 40 years of dedication in the space. Visit The Amputee Coalition to learn more about how you can help fuel the next 40 years—in a way that’s authentic to you! https://lnkd.in/eZ_i9EGM

Your Friday plans for #SCAI2026, delivered. Dr. Ramzan Zakir and Sameh Sayfo, MD, MBA, FACC, FSCAI will be back in our Learning Lab Booth 810 tomorrow to share all about the #DETOURSystem, including data, patient selection, and tips for success. 🗓️ Friday, 4/24 Rethinking the Route: PTAB with DETOUR for Challenging SFA Cases – A deep dive look into the DETOUR clinical evidence, patient selection guidelines and procedural tips for a successful procedure 10:00 am - 11:00 am | Dr. Sameh Sayfo 3:00 pm - 4:00 pm | Dr. Ramzan Zakir Learn about the DETOUR System here: https://lnkd.in/geiZmcEX Society for Cardiovascular Angiography & Interventions #PeripheralArteryDisease #medtech #healthcareinnovation #endovascularinnovation #medicalinnovation #percutaneous Disclaimer: The DETOUR System is not approved for use outside of the U.S.

We are looking forward to hearing from Aravinda Nanjundappa M.B.B.S., FSCAI, at the podium on Saturday during #SCAI2026. He'll be sharing his real-world insights on using #PTAB with the #DETOURSystem for patients with complex SFA occlusion. If your current endovascular interventions for these patients aren't providing the results your patients need, put this one on your calendar to hear how the DETOUR System delivers. Podium Presentation: DETOUR Percutaneous SFA Bypass for Complex SFA Occlusion 🗓️Saturday, April 25 ⌚️11:38 AM - 11:45 AM 📍SCAI Central (517) Room 800 (5th level, Palais des Congres de Montreal) Important Safety Information: https://lnkd.in/gQvqV2Kn Society for Cardiovascular Angiography & Interventions #PeripheralArteryDisease #medtech #healthcareinnovation #medtwitter #cardiotwitter #endovascularinnovation #medicalinnovation Disclaimer: The DETOUR System is not approved for use outside of the U.S.

Tomorrow at #SCAI2026! Make plans to visit our Learning Lab Booth 810 for real-world insights from Dr. Ramzan Zakir and Sameh Sayfo, MD, MBA, FACC, FSCAI on #PTAB with the #DETOURSystem. 🗓️ Thursday, 4/23 Pioneers of Progress: Real-World Insights with the DETOUR System – Offering an in-depth look at DETOUR – a groundbreaking approach to treating complex SFA disease through percutaneous transmural arterial bypass (PTAB) 11:00 am - 12:00 pm | Dr. Ramzan Zakir 3:00 pm - 4:00 pm | Dr. Sameh Sayfo Learn about the DETOUR System here: https://lnkd.in/geiZmcEX Society for Cardiovascular Angiography & Interventions #PeripheralArteryDisease #medtech #healthcareinnovation #endovascularinnovation #medicalinnovation #percutaneous #SFA Disclaimer: The DETOUR System is not approved for use outside of the U.S.

Late-breaker presentation at #SCAI2026! Sameh Sayfo, MD, MBA, FACC, FSCAI, will be sharing the results of RODEO-PTAB, a substudy of DETOUR2, that assessed safety and efficacy outcomes after #PTAB for patients with one runoff vessel compared to patients who had more than one runoff vessel. This is the first time distal runoff has been evaluated as a predictor of outcomes after PTAB. RODEO-PTAB: RunOff Determinants of Endovascular Outcomes after PTAB in Patients with Single-Vessel Outflow, A multi-Variants Analysis (DETOUR II Substudy) 🗓️Thursday, April 23 ⌚️11:38 AM - 11:46 AM 📍SCAI Central, 517abcd, Theater 3 Learn about the #DETOURSystem here: https://lnkd.in/geiZmcEX Society for Cardiovascular Angiography & Interventions #PeripheralArteryDisease #medtech #healthcareinnovation #medtwitter #cardiotwitter #endovascularinnovation #medicalinnovation #percutaneous Disclaimer: The DETOUR System is not approved for use outside of the U.S.

What better to learn about a technology than with it in your hands! Come to our Learning Lab Booth 810 at #SCAI2026 to get hands-on with the #DETOURSystem in a variety of immersive experiences. -Product simulator -Pedal access training -VR Find out why physicians across the United States are adding fully percutaneous bypass to their treatment toolbox for long, complex #SFA disease. See you there! Learn about the DETOUR System here: https://lnkd.in/geiZmcEX #PeripheralArteryDisease #medtech #healthcareinnovation #medtwitter #cardiotwitter #endovascularinnovation #medicalinnovation #percutaneous Disclaimer: The DETOUR System is not approved for use outside of the U.S.